Home » Topics » Regulatory » Patents

Patents
RSS

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Preparation and use of peptide bradykinin B2 receptor agonists described by Fournier

Sep. 14, 1998

Antiplatelet compounds developed by Merck & Co.

Sep. 14, 1998

Inhibitors of sPLA2 claimed by Lilly for septic shock, etc.

Sep. 14, 1998

Synthelabo compounds act as 5-HT receptor ligands

Sep. 14, 1998

Fujisawa scientists synthesize new series of vasopressin antagonists

Sep. 10, 1998

Natural nonpeptide inhibitors of protein farnesyltransferase discovered at Merck & Co.

Sep. 10, 1998

Schering-Plough prepares arylalkylamines as neurokinin antagonists

Sep. 10, 1998

U.S. university researchers discover nucleoside analogues for EBV

Sep. 9, 1998

New diagnostic agents described in patent literature by Schering AG

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...